a 2-month therapy with 1.25 mg of gestrinone daily induced a degree of cellular inactivation and degeneration of the endometriotic implants that was more pronounced than after 4 months of therapy with either gestrinone ( 2.5 mg twice or thrice weekly ) or danazol ( 600 mg daily ) .
C0014175
endometriotic
C0010961
danazol